Ellen H. M. de Kort
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ellen H. M. de Kort has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Sinno H. P. Simons
Division of Neonatology Department of Pediatrics Erasmus UMC – Sophia Children’s Hospital Rotterdam the Netherlands
4 shared publicationsIrwin K. M. Reiss
Division of Neonatology Department of Pediatrics Erasmus UMC – Sophia Children's Hospital Rotterdam The Netherlands
3 shared publicationsMirjam M. van Weissenbruch
Division of Neonatology Department of Pediatrics Amsterdam UMC Location VU University Medical Center Amsterdam The Netherlands
2 shared publications- Peter Andriessen
Maxima Medical Center
2 shared publications Carola van Pul
Human & Technology, Biometrics, Zuyd University of Applied Sciences, Heerlen, The Netherlands
1 shared publicationEllen P. G. van T Verlaat
Division of Neonatology Department of Pediatrics Erasmus UMC – Sophia Children's Hospital Rotterdam The Netherlands
1 shared publication
Latest Publications
- 14 January 2021
- Published by Wiley in Acta Paediatrica
- Vol. 110 (5) , 1693
Reply to Letter ‘Propofol in preterm neonates’
In their letter, Meyer et al. cite the fact that propofol is not registered for use in infants less than one month of age.2 We are well aware of this fact. This does not only apply to propofol but is the case for a substantial amount of drugs used in the neonatal population. In a recent survey, Flint et al. showed that 23% of drug prescriptions were off‐label in relation to neonatal age and over half of all newborns admitted to the neonatal intensive care unit (NICU) received at least one off‐label drug.
- 14 January 2021
- Published by Wiley in Acta Paediatrica
- Vol. 110 (5) , 1693
Reply to Letter ‘Propofol in preterm neonates’
In their letter, Meyer et al. cite the fact that propofol is not registered for use in infants less than one month of age.2 We are well aware of this fact. This does not only apply to propofol but is the case for a substantial amount of drugs used in the neonatal population. In a recent survey, Flint et al. showed that 23% of drug prescriptions were off‐label in relation to neonatal age and over half of all newborns admitted to the neonatal intensive care unit (NICU) received at least one off‐label drug.
- Open Access
- 5 April 2020
- Published by Wiley in Acta Paediatrica
- Vol. 109 (12) , 2539-2546
Propofol in neonates causes a dose‐dependent profound and protracted decrease in blood pressure
Aim: To analyse the effects of different propofol starting doses as premedication for endotracheal intubation on blood pressure in neonates.Methods: Neonates who received propofol starting doses of 1.0 mg/kg (n = 30), 1.5 mg/kg (n = 23) or 2.0 mg/kg (n = 26) as part of a previously published dose‐finding study were included in this analysis. Blood pressure in the 3 dosing groups was analysed in the first 60 minutes after start of propofol.Results: Blood pressure declined after the start of propofol in all 3 dosing groups and was not restored 60 minutes after the start of propofol. The decline in blood pressure was highest in the 2.0 mg/kg dosing group. Blood pressure decline was mainly dependent on the initial propofol starting dose rather than the cumulative propofol dose.Conclusion: Propofol causes a dose‐dependent profound and prolonged decrease in blood pressure. The use of propofol should be carefully considered. When using propofol, starting with a low dose and titrating according to sedative effect seems the safest strategy.
- 5 April 2020
- Published by Wiley in Acta Paediatrica
- Vol. 109 (12) , 2539-2546
Open AccessPropofol in neonates causes a dose‐dependent profound and protracted decrease in blood pressure
Aim: To analyse the effects of different propofol starting doses as premedication for endotracheal intubation on blood pressure in neonates.Methods: Neonates who received propofol starting doses of 1.0 mg/kg (n = 30), 1.5 mg/kg (n = 23) or 2.0 mg/kg (n = 26) as part of a previously published dose‐finding study were included in this analysis. Blood pressure in the 3 dosing groups was analysed in the first 60 minutes after start of propofol.Results: Blood pressure declined after the start of propofol in all 3 dosing groups and was not restored 60 minutes after the start of propofol. The decline in blood pressure was highest in the 2.0 mg/kg dosing group. Blood pressure decline was mainly dependent on the initial propofol starting dose rather than the cumulative propofol dose.Conclusion: Propofol causes a dose‐dependent profound and prolonged decrease in blood pressure. The use of propofol should be carefully considered. When using propofol, starting with a low dose and titrating according to sedative effect seems the safest strategy.
- Open Access
- 13 January 2020
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (5) , 489-495
Propofol for endotracheal intubation in neonates: a dose-finding trial
Objective To find propofol doses providing effective sedation without side effects in neonates of different gestational ages (GA) and postnatal ages (PNA). Design and setting Prospective multicentere dose-finding study in 3 neonatal intensive care units. Patients Neonates with a PNA Interventions Neonates were stratified into 8 groups based on GA and PNA. The first 5 neonates in every group received a dose of 1.0 mg/kg propofol. Based on sedative effect and side effects, the dose was increased or decreased in the next 5 patients until the optimal dose was found. Main outcome measures The primary outcome was the optimal single propofol starting dose that provides effective sedation without side effects in each age group. Results After inclusion of 91 patients, the study was prematurely terminated because the primary outcome was only reached in 13% of patients. Dose-finding was completed in 2 groups, but no optimal propofol dose was found. Effective sedation without side effects was achieved more often after a starting dose of 2.0 mg/kg (28%) than after 1.0 mg/kg (3%) and 1.5 mg/kg (9%). Propofol-induced hypotension occurred in 59% of patients. Logistic regression analyses showed that GA and PNA did not predict effective sedation or the occurrence of hypotension. Conclusions Effective sedation without side effects is difficult to achieve with propofol and the optimal dose in different age groups of neonates could not be determined. The sedative effect of propofol and the occurrence of hypotension are unpredictable and show large inter-individual variability in the neonatal population.
- 13 January 2020
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (5) , 489-495
Open AccessPropofol for endotracheal intubation in neonates: a dose-finding trial
Objective To find propofol doses providing effective sedation without side effects in neonates of different gestational ages (GA) and postnatal ages (PNA). Design and setting Prospective multicentere dose-finding study in 3 neonatal intensive care units. Patients Neonates with a PNA Interventions Neonates were stratified into 8 groups based on GA and PNA. The first 5 neonates in every group received a dose of 1.0 mg/kg propofol. Based on sedative effect and side effects, the dose was increased or decreased in the next 5 patients until the optimal dose was found. Main outcome measures The primary outcome was the optimal single propofol starting dose that provides effective sedation without side effects in each age group. Results After inclusion of 91 patients, the study was prematurely terminated because the primary outcome was only reached in 13% of patients. Dose-finding was completed in 2 groups, but no optimal propofol dose was found. Effective sedation without side effects was achieved more often after a starting dose of 2.0 mg/kg (28%) than after 1.0 mg/kg (3%) and 1.5 mg/kg (9%). Propofol-induced hypotension occurred in 59% of patients. Logistic regression analyses showed that GA and PNA did not predict effective sedation or the occurrence of hypotension. Conclusions Effective sedation without side effects is difficult to achieve with propofol and the optimal dose in different age groups of neonates could not be determined. The sedative effect of propofol and the occurrence of hypotension are unpredictable and show large inter-individual variability in the neonatal population.
- 27 August 2019
- Published by Springer Nature in Pediatric Research
- Vol. 87 (1) , 125-130
Quality assessment and response to less invasive surfactant administration (LISA) without sedation
Background Although sedative premedication for endotracheal intubation is considered standard of care, less invasive surfactant administration (LISA) is often performed without sedative premedication. Objective To assess success rates, technical quality and vital parameters in LISA without sedative premedication. Methods Prospective observational study in 86 neonates <32 weeks’ gestation. LISA was performed according to a standardized protocol without use of sedative premedication. Outcome measures were success rates of LISA attempts, reasons for failure and quality of technical conditions. In 37 neonates, heart rate and oxygen saturation levels from 20 min before until 30 min after start of LISA were collected. Results In 48% of LISAs the first attempt failed and in 34% quality of technical conditions was inadequate. The success rate was significantly correlated with quality of technical conditions and experience of the performer. Desaturations <80% occurred in 54% of patients while bradycardia <80/min did not occur. Conclusion This study shows a relatively low success rate of the first attempt of LISA, frequent inadequacy of technical quality and frequent oxygen desaturations. These effects may be improved by the use of sedative premedication.
- 27 August 2019
- Published by Springer Nature in Pediatric Research
- Vol. 87 (1) , 125-130
Quality assessment and response to less invasive surfactant administration (LISA) without sedation
Background Although sedative premedication for endotracheal intubation is considered standard of care, less invasive surfactant administration (LISA) is often performed without sedative premedication. Objective To assess success rates, technical quality and vital parameters in LISA without sedative premedication. Methods Prospective observational study in 86 neonates <32 weeks’ gestation. LISA was performed according to a standardized protocol without use of sedative premedication. Outcome measures were success rates of LISA attempts, reasons for failure and quality of technical conditions. In 37 neonates, heart rate and oxygen saturation levels from 20 min before until 30 min after start of LISA were collected. Results In 48% of LISAs the first attempt failed and in 34% quality of technical conditions was inadequate. The success rate was significantly correlated with quality of technical conditions and experience of the performer. Desaturations <80% occurred in 54% of patients while bradycardia <80/min did not occur. Conclusion This study shows a relatively low success rate of the first attempt of LISA, frequent inadequacy of technical quality and frequent oxygen desaturations. These effects may be improved by the use of sedative premedication.
- 20 November 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (1) , 28-36
Assessment of sedation level prior to neonatal intubation: A systematic review
Summary: Background: Adequate premedication before neonatal endotracheal intubation reduces pain, stress, and adverse physiological responses, diminishes duration and number of attempts at intubation, and prevents traumatic airway injury. Therefore, intubation should not be started until an adequate level of sedation is reached. It is not clear how this should be measured in the clinical situation.Objectives: The aim of this study is to provide a systematic review of the usability and validity of scoring systems or other objective parameters to evaluate the level of sedation before intubation in neonates. Secondary aims were to describe parameters that are used to determine the level of sedation and criteria on which the decision to proceed with intubation is based.Methods: Literature was searched (January 2017) in the following electronic databases: Embase, Medline, Web of Science, Cochrane Central Registrar of Controlled Trials, Pubmed Publisher, and Google Scholar.Results: From 1653 hits, 20 studies were finally included in the systematic review. In 7 studies, intubation was started after a predefined time period; in 1 study, preoxygenation was the criterion to start with intubation; and in 12 studies, intubation was started in case of adequate sedation and/or relaxation. Only 4 studies described the use of 3 different objective scoring system, all in the neonatal intensive care unit, which are not validated.Conclusion: No validated scoring systems to assess the level of sedation prior to intubation in newborns are available in the literature. Three objective sedation assessment tools seem promising but need further validation before they can be implemented in research and clinical settings.
- 20 November 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (1) , 28-36
Assessment of sedation level prior to neonatal intubation: A systematic review
Summary: Background: Adequate premedication before neonatal endotracheal intubation reduces pain, stress, and adverse physiological responses, diminishes duration and number of attempts at intubation, and prevents traumatic airway injury. Therefore, intubation should not be started until an adequate level of sedation is reached. It is not clear how this should be measured in the clinical situation.Objectives: The aim of this study is to provide a systematic review of the usability and validity of scoring systems or other objective parameters to evaluate the level of sedation before intubation in neonates. Secondary aims were to describe parameters that are used to determine the level of sedation and criteria on which the decision to proceed with intubation is based.Methods: Literature was searched (January 2017) in the following electronic databases: Embase, Medline, Web of Science, Cochrane Central Registrar of Controlled Trials, Pubmed Publisher, and Google Scholar.Results: From 1653 hits, 20 studies were finally included in the systematic review. In 7 studies, intubation was started after a predefined time period; in 1 study, preoxygenation was the criterion to start with intubation; and in 12 studies, intubation was started in case of adequate sedation and/or relaxation. Only 4 studies described the use of 3 different objective scoring system, all in the neonatal intensive care unit, which are not validated.Conclusion: No validated scoring systems to assess the level of sedation prior to intubation in newborns are available in the literature. Three objective sedation assessment tools seem promising but need further validation before they can be implemented in research and clinical settings.
- 23 January 2014
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (5) , 1332-1333
A case of Rubinstein‐Taybi syndrome and congenital neuroblastoma
- 23 January 2014
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (5) , 1332-1333
A case of Rubinstein‐Taybi syndrome and congenital neuroblastoma
- Open Access
- 23 December 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Sedation of Newborn Infants for the INSURE Procedure, Are We Sure?
Background. Neonatal intubation is a stressful procedure that requires premedication to improve intubation conditions and reduce stress and adverse physiological responses. Premedication used during the INSURE (INtubation, SURfactant therapy, Extubation) procedure should have a very short duration of action with restoration of spontaneous breathing within a few minutes.Aims. To determine the best sedative for intubation during the INSURE procedure by systematic review of the literature.Methods. We reviewed all relevant studies reporting on premedication, distress, and time to restoration of spontaneous breathing during the INSURE procedure.Results. This review included 12 studies: two relatively small studies explicitly evaluated the effect of premedication (propofol and remifentanil) during the INSURE procedure, both showing good intubation conditions and an average extubation time of about 20 minutes. Ten studies reporting on fentanyl or morphine provided insufficient information about these items.Conclusions. Too little is known in the literature to draw a solid conclusion on which premedication could be best used during the INSURE procedure. Both remifentanil and propofol are suitable candidates but dose-finding studies to detect effective nontoxic doses in newborns with different gestational ages are necessary.
- 23 December 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Open AccessSedation of Newborn Infants for the INSURE Procedure, Are We Sure?
Background. Neonatal intubation is a stressful procedure that requires premedication to improve intubation conditions and reduce stress and adverse physiological responses. Premedication used during the INSURE (INtubation, SURfactant therapy, Extubation) procedure should have a very short duration of action with restoration of spontaneous breathing within a few minutes.Aims. To determine the best sedative for intubation during the INSURE procedure by systematic review of the literature.Methods. We reviewed all relevant studies reporting on premedication, distress, and time to restoration of spontaneous breathing during the INSURE procedure.Results. This review included 12 studies: two relatively small studies explicitly evaluated the effect of premedication (propofol and remifentanil) during the INSURE procedure, both showing good intubation conditions and an average extubation time of about 20 minutes. Ten studies reporting on fentanyl or morphine provided insufficient information about these items.Conclusions. Too little is known in the literature to draw a solid conclusion on which premedication could be best used during the INSURE procedure. Both remifentanil and propofol are suitable candidates but dose-finding studies to detect effective nontoxic doses in newborns with different gestational ages are necessary.